‹
›
This content requires a premium subscription.
Please
log in
or
subscribe
to continue.
Dermatology Weekly
Tools to aid in clinical decision making; plus safety data for tacrolimus; results of a phase 3 study of an IL-17A inhibitor; and clinician burnout.
30
00:00:00
/ 00:27:07
30